Kaiser FluMist Safety Data Analysis To Be Submitted To FDA By Year-End

Aviron expects to submit to FDA the full analysis of a FluMist pediatric safety study conducted at Kaiser Permanente outpatient clinics by the end of the year.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet